Neurogenic hypertension

Experimental Physiology

Volumn 95, Issue 5, 2010, Pages 569-571

  Paton, Julian F R ^a   Raizada, Mohan K ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; CATECHOLAMINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMIDAZOLINE; INSULIN; LEPTIN; RANTES; SODIUM CHLORIDE;

AUTONOMIC NERVOUS SYSTEM; BLOOD BRAIN BARRIER; BLOOD PRESSURE REGULATION; BRAIN FUNCTION; DIABETES MELLITUS; DISEASE ASSOCIATION; EDITORIAL; EXERCISE; HEART ARRHYTHMIA; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; IRELAND; JAPAN; MUSCLE BLOOD VESSEL; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PERONEUS NERVE; PHYSICAL ACTIVITY; PREVALENCE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYMPATHETIC TONE; SYMPOSIUM; VASCULITIS;

EID: 77951162009     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2009.047282     Document Type: Editorial

References (5)

1. Grassi G, Seravalle G Quarti-Trevano F (2010). The 'neuroadrenergic hypothesis' in hypertension: current evidence. Exp Physiol 95, 581 586.
2. Feng Y, Xia H, Santos RA, Speth R Lazartigues E (2010). Angiotensin-converting enzyme 2: a new target for neurogenic hypertension. Exp Physiol 95, 601 606.
3. Fisher JP Fadel PJ (2010). Therapeutic strategies for targeting excessive central sympathetic activation in human hypertension. Exp Physiol 95, 572 580.
4. Toney GM, Pedrino GR, Fink GD Osborn JW (2010). Does enhanced respiratory-sympathetic coupling contribute to peripheral neural mechanisms of angiotensin II-salt hypertension? Exp Physiol 95, 587 594.
5. Waki H, Gouraud SS, Maeda M Paton JFR (2010). Evidence of specific inflammatory condition in nucleus tractus solitarii of neurogenic hypertension. Exp Physiol 95, 595 600.